What Each Sterilization Monitor Can—and Cannot—Tell You

Effective sterilization monitoring does not depend on a single indicator or record. Mechanical, chemical, and biological monitors provide different types of evidence, and each has limitations. The practical task is to interpret the results together in the context of the sterilizer, sterilization method, load, packaging, and established procedures. CDC recommends using mechanical, chemical, and biological monitoring as complementary elements rather than treating one type as a substitute for the others [1,5].

Start with the question each monitor addresses

A monitoring program can be organized around three questions:

• Did the sterilizer record the intended process conditions?
• Did the sterilant reach the monitoring location or package?
• Did the process inactivate the microbial challenge represented by the biological indicator?

These questions overlap, but they are not interchangeable. A favorable result from one monitor does not automatically answer the others. The applicable sterilizer instructions, indicator instructions for use, method-specific guidance, validated process documentation, and facility procedures should determine how results are reviewed and how loads are handled.

Mechanical monitoring: what the equipment recorded

Mechanical monitoring involves reviewing the sterilizer’s measurements and cycle record. Depending on the process, recorded variables may include time, temperature, pressure, gas concentration, humidity, or other process conditions. For steam sterilization, CDC identifies review of cycle time, temperature, and pressure as part of mechanical monitoring. For ethylene oxide, time, temperature, and pressure are among the recorded variables, while some important conditions may not be directly monitored in healthcare sterilizers [1].

Mechanical data can show whether the recorded cycle met predefined acceptance criteria. They do not, by themselves, demonstrate that every location in a load received adequate sterilant exposure. A satisfactory display or printout can coexist with problems involving air removal, load arrangement, packaging, instrument geometry, or sterilant access. Mechanical monitoring therefore supports, but does not replace, chemical and biological monitoring.

Practical review points

• Confirm that the selected cycle is appropriate for the load.
• Compare recorded values with approved cycle requirements and local procedures.
• Check for alarms, interruptions, aborted phases, unusual records, or incomplete documentation.
• Connect the cycle record to the load identifier, operator, contents, and release decision.

Chemical indicators: response to specified process variables

Chemical indicators respond to one or more specified sterilization variables. An external process indicator can help distinguish processed from unprocessed packages, while an internal indicator provides information about conditions at a location inside the package. FDA describes process indicators, chemical integrators, and air-removal indicators as distinct types of chemical indicators used in healthcare settings [2].

The indicator’s response must be interpreted according to its instructions for use. A chemical endpoint does not independently establish that an item is sterile, that all required conditions were achieved throughout the load, or that microbial killing occurred. CDC notes that chemical indicators should be used with biological indicators because chemical indicators do not directly measure microbial killing [1].

Location also matters. An indicator placed inside a package, tray, or process challenge device provides evidence about the conditions experienced at that location. It does not necessarily represent every item or every position in the chamber. A failed or questionable chemical result should be managed through the facility’s hold and investigation procedure rather than dismissed because an external indicator changed.

Biological indicators: a defined microbial challenge

Biological indicators use standardized microorganisms with known resistance to the sterilization process. They challenge the process with resistant spores and indicate whether the conditions were adequate to inactivate that challenge. This makes biological indicators an important component of sterilization monitoring [1,3].

A negative biological-indicator result does not prove that every item in a load is sterile or that every location experienced identical conditions. CDC specifically cautions against interpreting a negative biological indicator as proof that all items were adequately exposed [4]. The result must be considered with the cycle record, chemical indicators, load configuration, packaging, and intended use of the load.

Why BI placement and controls matter

A biological indicator is meaningful only when it is appropriate for the sterilization process, used according to its instructions, placed within an appropriate challenge, and incubated or read correctly. The challenge location should follow the validated or established rationale for representing a difficult-to-sterilize condition. Traceability should connect the BI to the relevant load, sterilizer, location, operator, and readout.

Actions associated with a positive BI depend on the sterilization method and the applicable procedure. CDC recommendations distinguish among sterilization methods and provide method-specific monitoring and follow-up considerations, including considerations for steam and non-steam processes [1,5]. Facilities should therefore follow the applicable CDC recommendations, sterilizer and indicator instructions, validated procedures, and positive-BI policy rather than applying one response to every technology or load.

When monitoring results disagree

Disagreement among mechanical, chemical, and biological results should be treated as an investigation issue, not as a reason to assume that one monitor automatically overrides the others. The affected load may require a hold while authorized personnel verify the indicator type, expiration and storage conditions, placement, interpretation, cycle selection, packaging, load configuration, and mechanical record.

For a positive BI, the review may also include control results, incubation or readout records, indicator handling, recent maintenance, and process changes. FDA identifies biological-indicator testing, chemical-indicator testing, process-record review, and other verification activities as elements of sterilization process control. That FDA source primarily addresses sterilization process controls in medical-device manufacturing and validation; it should not be read as a general CSSD release protocol [3].

An abnormal mechanical record still requires evaluation even when chemical or biological results are acceptable. Conversely, a favorable mechanical record does not eliminate the need to address a failed chemical indicator or positive BI. Load disposition should follow the applicable method-specific procedure and be documented by an authorized person.

Build release decisions from a complete record

A defensible release process uses predefined criteria rather than informal judgment. The record should connect, as applicable:

• sterilizer and cycle identification;
• load number and contents;
• mechanical or electronic cycle record;
• chemical monitoring results and locations;
• biological monitoring results when required by policy, process, or load type;
• operator identification;
• package or container inspection findings; and
• the release decision and any exception investigation.

CDC recommends recording the sterilizer and cycle, load identification, contents, exposure parameters, operator, and mechanical, chemical, and biological monitoring results [5]. A complete record supports reconstruction of what happened and shows how an exception was evaluated. It does not turn any individual monitor into proof beyond its intended role.

The central interpretation

Mechanical monitors describe recorded process conditions. Chemical indicators respond to specified process variables at the location where they are used. Biological indicators challenge the process with a defined microbial challenge. Each contributes different evidence, and none should be interpreted outside its intended role.

This framework does not replace the sterilizer manufacturer’s instructions, indicator instructions for use, validated process documentation, applicable regulations, or facility policy. Monitoring expectations may differ by sterilization technology, load type, jurisdiction, and setting. The FDA material cited here may also apply specifically to medical-device manufacturing and validation activities rather than routine CSSD release decisions [3].

Educational disclaimer: This article is for professional education and does not replace applicable standards, regulations, manufacturer instructions, validated procedures, or competent technical review.

References

1. Sterilizing Practices. Centers for Disease Control and Prevention. 2023-11-28.
2. Premarket Notification (510(k)) Submissions for Chemical Indicators. U.S. Food and Drug Administration. 2002-01-01.
3. Sterilization Process Controls. U.S. Food and Drug Administration. 2022-01-01.
4. Glossary: Biologic Indicator. Centers for Disease Control and Prevention. 2024-01-01.
5. Summary Recommendations: Monitoring of Sterilizers. Centers for Disease Control and Prevention. 2024-01-01.

Educational overview. Follow the applicable product instructions, validated procedures, local regulations and your facility’s approved policies.